Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Griffin, Clare"'
Autor:
Brand DH; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK., Tree AC; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK., Ostler P; Mount Vernon Cancer Centre, Northwood, UK., van der Voet H; The James Cook University Hospital, Middlesbrough, UK., Loblaw A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Ford D; University Hospitals Birmingham, Birmingham, UK., Tolan S; The Clatterbridge Cancer Centre, Birkenhead, UK., Jain S; Queen's University Belfast, Belfast, UK., Martin A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Staffurth J; Cardiff University, Cardiff, UK., Camilleri P; Churchill Hospital, Oxford, UK., Kancherla K; University Hospitals of Leicester, Leicester, UK., Frew J; Freeman Hospital, Newcastle, UK., Chan A; University Hospitals Coventry & Warwickshire, Coventry, UK., Dayes IS; Department of Oncology, McMaster University, Hamilton, ON, Canada., Henderson D; University Hospitals Birmingham, Birmingham, UK., Brown S; The Institute of Cancer Research, London, UK., Cruickshank C; The Institute of Cancer Research, London, UK., Burnett S; The Institute of Cancer Research, London, UK., Duffton A; Beatson West of Scotland Cancer Centre, Glasgow, UK., Griffin C; The Institute of Cancer Research, London, UK., Hinder V; The Institute of Cancer Research, London, UK., Morrison K; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK., Naismith O; The Royal Marsden Hospital, London, UK., Hall E; The Institute of Cancer Research, London, UK., van As N; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK. Electronic address: nicholas.vanas@rmh.nhs.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Nov; Vol. 20 (11), pp. 1531-1543. Date of Electronic Publication: 2019 Sep 17.
Autor:
Wilson JM; Guy's and St. Thomas' NHS Foundation Trust/Kings College, London, UK., Dearnaley DP; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: david.dearnaley@icr.ac.uk., Syndikus I; Clatterbridge Cancer Centre, Wirral, UK., Khoo V; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Birtle A; Rosemere Cancer Centre, Royal Preston Hospital/University of Manchester, Preston, UK., Bloomfield D; Brighton and Sussex University Hospitals, Brighton, UK., Choudhury A; Christie Hospital, Manchester, UK., Graham J; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Ferguson C; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK., Malik Z; Clatterbridge Cancer Centre, Wirral, UK., Money-Kyrle J; Royal Surrey County Hospital, Guildford, UK., O'Sullivan JM; Queen's University Belfast, Belfast, UK., Panades M; Lincoln County Hospital, Lincoln, UK., Parker C; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Rimmer Y; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Scrase C; Ipswich Hospital, Ipswich, UK., Staffurth J; Cardiff University/Velindre Cancer Centre, Cardiff, UK., Stockdale A; University Hospital Coventry, Coventry, UK., Cruickshank C; The Institute of Cancer Research, London, UK., Griffin C; The Institute of Cancer Research, London, UK., Hall E; The Institute of Cancer Research, London, UK.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Apr 01; Vol. 100 (5), pp. 1179-1189. Date of Electronic Publication: 2018 Jan 09.
Autor:
Dearnaley D; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: David.Dearnaley@icr.ac.uk., Syndikus I; Clatterbridge Cancer Centre, Wirral, UK., Mossop H; The Institute of Cancer Research, London, UK., Khoo V; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Birtle A; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK., Bloomfield D; Brighton and Sussex University Hospitals, Brighton, UK., Graham J; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Kirkbride P; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK., Logue J; Christie Hospital, Manchester, UK., Malik Z; Clatterbridge Cancer Centre, Wirral, UK., Money-Kyrle J; Royal Surrey County Hospital, Guildford, UK., O'Sullivan JM; Queen's University Belfast, Belfast, UK., Panades M; Lincoln County Hospital, Lincoln, UK., Parker C; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Patterson H; Addenbrooke's Hospital, Cambridge, UK., Scrase C; Ipswich Hospital, Ipswich, UK., Staffurth J; Cardiff University/Velindre Cancer Centre, Cardiff, UK., Stockdale A; University Hospital Coventry, Coventry, UK., Tremlett J; Brighton and Sussex University Hospitals, Brighton, UK., Bidmead M; Royal Marsden NHS Foundation Trust, London, UK., Mayles H; Clatterbridge Cancer Centre, Wirral, UK., Naismith O; Royal Marsden NHS Foundation Trust, London, UK., South C; Royal Surrey County Hospital, Guildford, UK., Gao A; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Cruickshank C; The Institute of Cancer Research, London, UK., Hassan S; The Institute of Cancer Research, London, UK., Pugh J; The Institute of Cancer Research, London, UK., Griffin C; The Institute of Cancer Research, London, UK., Hall E; The Institute of Cancer Research, London, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2016 Aug; Vol. 17 (8), pp. 1047-1060. Date of Electronic Publication: 2016 Jun 20.
Autor:
Wilkins A; The Institute of Cancer Research, London, UK., Mossop H; The Institute of Cancer Research, London, UK., Syndikus I; Clatterbridge Cancer Centre, Wirral, UK., Khoo V; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Bloomfield D; Brighton and Sussex University Hospitals, Brighton, UK., Parker C; Royal Marsden NHS Foundation Trust, London, UK., Logue J; Christie Hospital, Manchester, UK., Scrase C; Ipswich Hospital, Ipswich, UK., Patterson H; Addenbrooke's Hospital, Cambridge, UK., Birtle A; Rosemere Cancer Centre, Royal Preston Hospital, UK., Staffurth J; Cardiff University, Cardiff, UK; Velindre Cancer Centre, Cardiff, UK., Malik Z; Whiston Hospital, Prescot, UK., Panades M; Lincoln County Hospital, Lincoln, UK., Eswar C; Southport General Infirmary, Southport, UK., Graham J; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Russell M; Beatson West of Scotland Cancer Centre, Glasgow, UK., Kirkbride P; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK., O'Sullivan JM; Queen's University Belfast, Belfast, UK., Gao A; The Institute of Cancer Research, London, UK., Cruickshank C; The Institute of Cancer Research, London, UK., Griffin C; The Institute of Cancer Research, London, UK., Dearnaley D; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Hall E; The Institute of Cancer Research, London, UK. Electronic address: emma.hall@icr.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2015 Dec; Vol. 16 (16), pp. 1605-16. Date of Electronic Publication: 2015 Oct 28.
Autor:
Haviland, Joanne S, Mannino, Mariella, Griffin, Clare, Porta, Nuria, Sydenham, Mark, Bliss, Judith M., Yarnold, John R.
Publikováno v:
Radiotherapy and Oncology
Background and purpose Adjuvant lymphatic radiotherapy (LNRT) is recommended for selected axillary node positive women with early breast cancer. We investigated whether hypofractionated LNRT is safe combined with similarly-hypofractionated breast/che